Basics ALX Oncology Holdings Inc. IPO Date: July 17, 2020 Sector: Healthcare Industry: Biotech Market Cap: $30.23M Activated in VL: True Average Daily Range Avg Daily Range: $0.90 | 3.94% Avg Daily Range (30 D): $0.03 | 4.11% Avg Daily Range (90 D): $0.06 | 5.04% Institutional Daily Volume Avg Daily Volume: .42M Avg Daily Volume (30 D): .43M Avg Daily Volume (90 D): .86M Trade Size Avg Trade Size (Sh.): 98 Avg Trade Size (Sh.) (30 D): 236 Avg Trade Size (Sh.) (90 D): 221 Institutional Trades Total Inst.Trades: 825 Avg Inst. Trade: $1.85M Avg Inst. Trade (30 D): $1.71M Avg Inst. Trade (90 D): $1.08M Avg Inst. Trade Volume: .08M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.96M Avg Closing Trade (30 D): $.83M Avg Closing Trade (90 D): $.83M Avg Closing Volume: 74.95K         News Mar 8, 2025 @ 12:33 PM Why the Global Cancer Market Could Surpass $900 Bi... Source: Prnewswire Dec 18, 2024 @ 1:00 PM ALX Oncology to Present Updated Results from Phase... Source: Alx Oncology Nov 1, 2024 @ 9:30 PM ALX Oncology Announces Results from Phase 1b/2 Tri... Source: Alx Oncology Oct 1, 2024 @ 5:00 PM Breast Cancer Clinical Trial Pipeline Appears Robu... Source: Delveinsight Jul 24, 2024 @ 8:02 AM EnerVenue Names Steffen Pietzke as Chief Financial... Source: N/A Financials   TTM Q4 2024 FY 2024 Basic EPS $-2.58 $-.53 $-2.58 Diluted EPS $-2.58 $-.53 $-2.58 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -134.85M $ -29.16M $ -134.85M Operating Income / Loss $ -142.47M $ -30.61M $ -142.47M Cost of Revenue $ $ $ Net Cash Flow $ -4.84M $ 1.47M $ -4.84M PE Ratio